| 2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
| FDA Comment Number : | EC999 | |||||||||||||||||||||||
| Submitter : | Ms. Cara Cameron | Date & Time: | 02/07/2006 04:02:39 | |||||||||||||||||||||
| Organization : | Ms. Cara Cameron | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Women are entitled to retain the right to access bioidentical hormone replacement therapy drugs, available only through compounding pharmacies. Please do not support the elimination of the compounding of bioidentical hormones as a treatment option for women of all ages. Thank you.
| ||||||||||||||||||||||||